OPEN END TURBO LONG - SHOCKWAVE MEDICAL Share Price

Certificat

DE000MB2N7C1

Market Closed - Börse Stuttgart 01:18:39 31/05/2024 am IST
2.02 EUR -0.49% Intraday chart for OPEN END TURBO LONG - SHOCKWAVE MEDICAL
3 months+45.32%
6 months+225.81%
Date Price Change
30/24/30 2.02 -0.49%
29/24/29 2.03 +0.50%
28/24/28 2.02 +1.00%
27/24/27 2 -0.99%
24/24/24 2.02 +0.50%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 01:18 am IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying SHOCKWAVE MEDICAL, INC.
Issuer Morgan Stanley
WKN MB2N7C
ISINDE000MB2N7C1
Date issued 23/01/2023
Strike 114.1 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.03
Lowest since issue 0.49

Company Profile

Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
Sector
-
More about the company

Ratings for Shockwave Medical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Shockwave Medical, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
334.8 USD
Average target price
326.1 USD
Spread / Average Target
-2.60%
Consensus